Back
Monopar Therapeutics Stock Predictions
Missed investing in Uber? Don't Miss Mode.
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
MNPR
Monopar Therapeutics
Last Price:
$39.20
Seasonality Move:
-13.19%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Monopar Therapeutics Stock Forecast
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 297% based on the past 5 years of stock performance.
-
Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Monopar Therapeutics Stock Undervalued?The current Monopar Therapeutics [MNPR] share price is $39.32. The Score for MNPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Monopar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 297% based on the past 5 years of stock performance.
Monopar Therapeutics Stock Rating
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics overpriced?
-
Monopar Therapeutics has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Monopar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com
52-Week Data
52-Week High:
38.50
52-Week Low:
1.55
Prediction Charts
Market Cap:
207.5M
Price in USD:
39.32
Volume:
102.1K
Beta:
1.25
Technical Analysis
SMA50:
23.59
SMA100:
15.43
SMA200:
9.39
52-Wk Change:
2114.59%
Stock Predictions
-
Is Monopar Therapeutics stock public?Yes, Monopar Therapeutics is a publicly traded company.
-
What is the Monopar Therapeutics stock quote today?The Monopar Therapeutics stock price is 39.32 USD today.
-
How to buy Monopar Therapeutics stock online?You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-2 | 22.00 | 22.22 | 23.00 | 21.81 |
| Jan-3 | 21.01 | 22.98 | 23.42 | 21.00 |
| Jan-6 | 23.73 | 23.60 | 24.00 | 22.50 |
| Jan-7 | 23.68 | 25.16 | 25.40 | 23.00 |
| Jan-8 | 25.00 | 24.46 | 25.00 | 23.87 |
| Jan-10 | 26.52 | 25.35 | 26.52 | 24.30 |
| Jan-13 | 25.90 | 25.69 | 26.00 | 25.15 |
| Jan-14 | 25.57 | 24.98 | 26.00 | 24.31 |
| Jan-15 | 24.63 | 26.91 | 26.91 | 24.00 |
| Jan-16 | 26.58 | 30.48 | 31.94 | 26.25 |
| Jan-17 | 31.30 | 28.54 | 31.95 | 26.67 |
| Jan-21 | 28.60 | 31.68 | 32.52 | 28.60 |
| Jan-22 | 33.76 | 33.67 | 35.00 | 31.95 |
| Jan-23 | 33.99 | 39.32 | 39.99 | 33.50 |
Monopar Therapeutics Earnings
Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monopar Therapeutics Forecast Revenue Growth
Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $2.41 per share.
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.